(Press-News.org) New Rochelle, NY, July 15, 2014—A new, validated software-based method for identifying patients with newly diagnosed HIV using electronic medical records (EMRs) is described in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers. The article is available free on the AIDS Research and Human Retroviruses website at http://online.liebertpub.com/doi/full/10.1089/aid.2013.0287 until August 15, 2014.
Providing medical care early on to people with newly diagnosed HIV infection is important for improving clinical outcomes. Study authors Matthew Bidwell Goetz and Tuyen Hoang, VA Greater Los Angeles Healthcare System and David Geffen School of Medicine, UCLA; Virginia Kan, Washington DC VA Medical Center and George Washington University School of Medicine; David Rimland, Atlanta VA Medical Center and Emory University School of Medicine; and Maria Rodriguez-Barradas, Michael E. DeBakey VA Medical Center and Baylor University School of Medicine, Houston, TX, developed an algorithm designed to search EMRs to identify patients with new diagnoses of HIV infection based on the sequence of HIV diagnostic testing, diagnostic code entries into the EMR, and measurements of HIV genetic material in blood samples. They tested and validated their software tool using EMRs from patients undergoing HIV testing from 2006-2012 at four large Veterans Health Administration facilities.
The authors report the sensitivity, specificity, and predictive value of the algorithm in the article "Development and Validation of an Algorithm to Identify Patients Newly Diagnosed with HIV Infection from Electronic Health Records."
"This paper describes new and valuable methodologies that will enhance the ability of public health officials to monitor increases in newly infected HIV populations," says Thomas Hope, PhD, Editor-in-Chief of AIDS Research and Human Retroviruses and Professor of Cell and Molecular Biology at the Feinberg School of Medicine, Northwestern University, Chicago, IL. "This will help to determine where healthcare resources for HIV-positive patients and testing for highest risk patients could be utilized more effectively. This will surely aid in facilitating the fight against HIV/AIDS."
INFORMATION:
About the Journal
AIDS Research and Human Retroviruses is published monthly in print and online. The Journal presents papers, reviews, and case studies documenting the latest developments and research advances in the molecular biology of HIV and SIV and innovative approaches to HIV vaccine and therapeutic drug research, including the development of antiretroviral agents and immune-restorative therapies. The content also explores the molecular and cellular basis of HIV pathogenesis and HIV/HTLV epidemiology. The Journal features rapid publication of emerging sequence information and reports on clinical trials of emerging HIV therapies. Tables of content and a sample issue may be viewed on the AIDS Research and Human Retroviruses website at http://www.liebertpub.com/aid.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including AIDS Patient Care and STDs, Viral Immunology, and Journal of Interferon and Cytokine Research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website at http://www.liebertpub.com.
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 http://www.liebertpub.com
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc., (914) 740-2100, kruehle@liebertpub.com
Identifying newly diagnosed HIV-infected people using electronic medical records
2014-07-15
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Researchers find organic pollutants not factor in turtle tumor disease
2014-07-15
For nearly four decades, scientists have suspected that persistent organic pollutants (POPs) contributed to a green turtle's susceptibility to the virus that causes fibropapilomatosis (FP), a disease that forms large benign tumors that can inhibit the animal's sight, mobility and feeding ability. In a new study,* researchers from the Hollings Marine Laboratory (HML), a government-university partner facility in Charleston, S.C., and from university and federal collaborators in Hawaii demonstrated POPs are not, in fact, a co-factor linked to the increasing number of green ...
Experts voice concerns over arsenic in rice, reports Journal of Pediatric Gastroenterology and Nutrition
2014-07-15
July 15, 2014 – Inorganic arsenic in rice and rice-based foods poses health concerns in infants and young children, and steps should be taken to minimize exposure, according to a commentary in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The inorganic arsenic levels ...
Oetzi's 'non-human' DNA
2014-07-15
Much of what we know about Oetzi – for example what he looked like or that he suffered from lactose intolerance – stems from a tiny bone sample which allowed the decoding of his genetic make-up. Now, however, the team of scientists have examined more closely the part of the sample consisting of non-human DNA. "What is new is that we did not carry out a directed DNA analysis but rather investigated the whole spectrum of DNA to better understand which organisms are in this sample and what is their potential function", is how Frank Maixner, from the EURAC Institute for Mummies ...
New mite species from a Caribbean mesophotic coral ecosystem named after J.Lo
2014-07-15
During a recent survey of organisms collected from Bajo de Sico, a mesophotic coral reef ecosystem in Mona Passage off Puerto Rico, one pontarachnid mite species new to science was discovered. The new species was named after the famous Puerto Rican singer Jennifer Lopez. The study was published in the open access journal ZooKeys.
"The reason behind the unusual choice of name for the new species", explains the lead author Vladimir Pešić, Department of Biology, University of Montenegro, "is that J.Lo's songs and videos kept the team in a continuous good mood when writing ...
Hidden variations in neuronal networks may explain differences in brain injury outcomes
2014-07-15
ATLANTA–A team of researchers at the Neuroscience Institute at Georgia State University has discovered that hidden differences in the properties of neural circuits can account for whether animals are behaviorally susceptible to brain injury. These results could have implications for the treatment of brain trauma.
People vary in their responses to stroke and trauma, which impedes the ability of physicians to predict patient outcomes. Damage to the brain and nervous system can lead to severe disabilities, including epilepsy and cognitive impairment.
If doctors could ...
Hidden variations in neuronal networks may explain traumatic brain injury outcomes
2014-07-15
A team of researchers at the Neuroscience Institute at Georgia State University has discovered that hidden differences in the properties of neural circuits can account for whether animals are behaviorally susceptible to brain injury. These results could have implications for the treatment of brain trauma.
People vary in their responses to stroke and trauma, which impedes the ability of physicians to predict patient outcomes. Damage to the brain and nervous system can lead to severe disabilities, including epilepsy and cognitive impairment.
If doctors could predict ...
To accept or not accept -- Patients want a say in liver transplant decisions
2014-07-15
A novel study reveals that more than half of liver transplant patients want to be informed of donor risk at the time a liver is offered for transplantation. Nearly 80% of those patients want to be involved in the decision of whether or not to accept the organ according to findings published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
There is a shortage of available donor organs, which leaves many on the liver transplant waiting list. Currently, there are more than ...
Cardiac patients underserved globally due to lack of rehab programs: York University researcher
2014-07-15
TORONTO, July 15, 2014 — Rehabilitation programs must become an integral part of cardiac care to significantly reduce the burden of living with heart disease, one of the most common chronic diseases and causes of death globally, according to York University Professor Sherry Grace.
"Cardiac rehabilitation is a cost-effective program offering heart patients exercise, education and risk reduction," says Grace, noting that participation results in 25 per cent less death, lower re-hospitalization rates and better quality of life.
Despite these benefits, cardiac rehabilitation ...
Neuropeptide Y protects cerebral cortical neurons
2014-07-15
Neuropeptide Y exhibits neuroprotective effects. Whether the neuroprotective effects are mediated by the pathways including regulating the immunological activity of reactive microglia and reducing cytokines remains unclear. Prof. Wenqing Zhao, Graduate School, Heibei Medical University, China and his team confirmed that neuropeptide Y prevented excessive production of interleukin-1β and tumor necrosis factor-α by inhibiting microglial reactivity, reduced N-methyl-D-aspartate current in rat cortical neurons, preventing excitotoxicity, and thereby protecting neurons. ...
Hippocampal neuron-related factor expression and neuronal injury after TBI
2014-07-15
Traumatic brain injury (TBI) causes gene expression changes in different brain regions. Cyclooxygenase-2, glutamate receptor-2, and platelet activating factor receptor expression levels are related to the occurrence and development of TBI. However, the precise relationship between the expression levels of these three factors and neuronal injury after TBI remains poorly understood. Zhiqiang Li, Inner Mongolia Corps Hospital, Chinese People's Armed Police Forces, China performed a study and showed that sequential expression of cyclooxygenase-2, glutamate receptor-2, and platelet ...